Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001834681-25-000005
Filing Date
2025-11-17
Accepted
2025-11-17 08:23:28
Documents
1
Period of Report
2025-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1763385804.html 4  
1 FORM 4 wk-form4_1763385804.xml 4 5032
  Complete submission text file 0001834681-25-000005.txt   6674
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
Niagen Bioscience, Inc. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 2443 FILLMORE ST #380-17649 SAN FRANCISCO CA 94115
Business Address
Pamir Ozan (Reporting) CIK: 0001834681 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37752 | Film No.: 251489429